PhRMA Proposing Two "Fast Tracks" To Limit Post-Approval Requirements
Executive Summary
The Pharmaceutical Research & Manufacturers of America is proposing that FDA adopt a two-tier "fast track" designation system to ensure that post-approval requirements apply only to products approved based on unconventional endpoints.